argenx SE (NASDAQ:ARGX) Q2 2024 Earnings Conference Call July 25, 2024 8:30 AM ET
Company Participants
Beth DelGiacco - Vice President, Global Head of Corporate Communications & Investor Relations
Tim Van Hauwermeiren - Chief Executive Officer
Karl Gubitz - Chief Financial Officer
Karen Massey - Chief Operating Officer
Conference Call Participants
James Gordon - JPMorgan
Tazeen Ahmad - Bank of America
Allison Bratzel - Piper Sandler
Rajan Sharma - Goldman Sachs
Derek Archila - Wells Fargo
Akash Tewari - Jefferies
Alex Thompson - Stifel
Thomas Smith - Leerink Partners
Yaron Werber - TD Cowen
Matt Phipps - William Blair
Suzanne van Voorthuizen - Kempen
Yatin Suneja - Guggenheim Partners
Vikram Purohit - Morgan Stanley
Charles Pitman-King - Barclays
Leland Gershell - Oppenheimer
Samantha Simankow - Citi
Joon Lee - Truist Securities
Gavin Clark-Gartner - Evercore ISI
Andy Chen - Wolfe Research
Joel Beatty - Baird
Douglas Tsao - H.C. Wainwright.
Operator
Good morning. My name is Adra and I will be your conference operator today. At this time, I would like to welcome everyone to the argenx Second Quarter 2024 Financial Results Conference Call. Today's conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
At this time, I would like to turn the conference over to Investor Relations, Beth DelGiacco. Please go ahead.
Beth DelGiacco
Thank you. A press release was issued earlier today with our half year 2024 financial results and second quarter business update. This can be found on our website along with the presentation for today's webcast.
Before we begin, I'd like to remind you that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory timelines, the potential success of our product candidates, financial